CLSI to Fund Platelet Function Testing Project Using Donor Restricted Funds
A message from CLSI’s Treasurer, Gerry Hoeltge, MD

During last year’s financial audit, CLSI’s auditors reviewed the organization’s temporarily-restricted funds. They recommended that residual balances from closed or inactive temporarily-restricted funds be returned to their respective donor organizations. Our policy is to retain financial records for seven years. The residual balances (totaling approximately $13,000) are more than a decade old, and we are unable to determine the donor organizations to which the funds should be returned.

The Finance Committee of the Board of Directors reviewed the audit recommendation and determined the residual funds should be used for standards-development projects if donor organizations cannot be identified. The Finance Committee has recommended that the residual balances be transferred to the new, temporarily-restricted fund on platelet function testing under the direction of the Area Committee on Hematology. This project will support the development of a guideline to improve the accuracy of diagnosing platelet hypo- and hyperactivity.

CLSI is committed to full disclosure of its financial records and adherence to generally accepted accounting practices for not-for-profit organizations. Discussions with our audit firm indicate the transfer of the residual balances to another temporarily-restricted fund would adequately address this audit recommendation. However, donor organizations are entitled to residual balances from closed or inactive temporarily-restricted funds; CLSI will gladly return such funds upon request and with proper documentation. Please contact Lola Pugliese, Vice President, Finance and Administration at lpugliese@clsi.org before 24 April with any requests for the return of these long-inactive restricted funds. Otherwise, the residual balances will be transferred to the new temporarily-restricted fund that will support the aforementioned platelet function testing project.

I would like to take this opportunity to thank those organizations who have contributed to our recent temporarily-restricted funds on point-of-care testing and platelet function testing. It is through the generous contributions of our member organizations that CLSI can continue to improve clinical and laboratory testing through standardization. I would also like to thank our volunteers, whose contributions of their time and expertise enable CLSI to develop standards and guidelines that are recognized worldwide. Together we continue to advance excellence in health care for current and future generations.

  [ return to top ]